[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
[2] |
Giordano SH. Breast cancer in men[J]. N Engl J Med, 2018, 379 (14): 1385-1386.
|
[3] |
Fabián-Estrada E, Flores-Rangel GA, Mosiñoz-Montes R, et al. Breast cancer in males, case presentation and literature review[J]. Rev Med Inst Mex Seguro Soc, 2018, 56(4): 424-428.
|
[4] |
Silvestri V, Barrowdale D, Mulligan AM, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2[J]. Breast Cancer Res, 2016, 18(1): 15.
|
[5] |
Miao H, Verkooijen HM, Chia KS, et al. Incidence and outcome of male breast cancer: an international population-based study[J]. J Clin Oncol, 2011, 29 (33): 4381-4386.
|
[6] |
Keinan-Boker L, Levine H, Leiba A, et al. Adolescent obesity and adult male breast cancer in a cohort of 1 382 093 men[J]. Int J Cancer, 2018, 142(5): 910-918.
|
[7] |
Sørensen HT, Friis S, Olsen JH, et al. Risk of breast cancer in men with liver cirrhosis[J]. Am J Gastroenterol, 1998, 93(2): 231-233.
|
[8] |
Olsson H, Alm P, Kristoffersson U, et al. Hypophyseal tumor and gynecomastia preceding bilateral breast cancer development in a man[J]. Cancer, 1984, 53(9): 1974-1977.
|
[9] |
Harris JR. Diseases of the breast[M]. U.S.A: LIPPINCOTT WILLIAMS & WILKINS, 2012: 1127-1135.
|
[10] |
Zheng Y, Mo W, Yu Y, et al. Breast carcinoma associated with prolactinoma: A case report[J]. Cancer Biol Ther, 2017, 18(3): 132-136.
|
[11] |
Goffin V. Prolactin receptor targeting in breast and prostate cancers: new insights into an old challenge[J]. Pharmacol Ther, 2017, 179: 111-126.
|
[12] |
Satram-Hoang S, Ziogas A, Anton-Culver H. Risk of second primary cancer in men with breast cancer[J]. Breast Cancer Res, 2007, 9(1): R10.
|
[13] |
Fentiman IS. Surgical options for male breast cancer[J]. Breast Cancer Res Treat, 2018, 172 (3): 539-544.
|
[14] |
焦武,姚峰. 男性乳腺癌的研究进展[J]. 中华实用诊断与治疗杂志, 2018, 32(5): 518-520.
|
[15] |
张铭钊,张建国. 男性乳腺癌的诊断与治疗[J]. 中国现代普通外科进展, 2017, 20(11): 922-924.
|
[16] |
Jordan VC. Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention[J]. Cancer Treat Rev, 1990, 17(1): 15-36.
|
[17] |
陈峰,邱丽贞. 芳香化酶抑制剂在早期男性乳腺癌治疗中的生物学效益及临床意义[J]. 中华医学杂志, 2014, 94(4): 273-275.
|